News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,785 Results
Type
Article (11479)
Company Profile (31)
Press Release (58272)
Multimedia
Podcasts (40)
Webinars (6)
Section
Business (16825)
Career Advice (1649)
Deals (2877)
Drug Delivery (55)
Drug Development (8478)
Employer Resources (111)
FDA (1840)
Job Trends (2183)
News (31884)
Policy (4666)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (679)
Accelerated approval (10)
Adcomms (13)
Allergies (35)
Alliances (4359)
ALS (31)
Alzheimer's disease (249)
Antibody-drug conjugate (ADC) (56)
Approvals (1773)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (6)
Bankruptcy (48)
Best Places to Work (1612)
BIOSECURE Act (11)
Biosimilars (29)
Biotechnology (22)
Bladder cancer (16)
Brain cancer (11)
Breast cancer (58)
Cancer (569)
Cardiovascular disease (57)
Career advice (1364)
Career pathing (31)
CAR-T (50)
CDC (22)
Cell therapy (152)
Cervical cancer (5)
Clinical research (6571)
Collaboration (221)
Company closure (3)
Compensation (52)
Complete response letters (14)
COVID-19 (780)
CRISPR (25)
C-suite (108)
Cystic fibrosis (16)
Data (672)
Decentralized trials (1)
Denatured (7)
Depression (36)
Diabetes (97)
Diagnostics (684)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (29)
Drug discovery (58)
Drug pricing (87)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (4952)
Editorial (54)
Employer branding (11)
Employer resources (102)
Events (8080)
Executive appointments (109)
FDA (2220)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (237)
Gene editing (51)
Generative AI (15)
Gene therapy (149)
GLP-1 (269)
Government (1070)
Grass and pollen (2)
Guidances (32)
Healthcare (2626)
HIV (21)
Huntington's disease (13)
IgA nephropathy (5)
Immunology and inflammation (61)
Immuno-oncology (18)
Indications (7)
Infectious disease (829)
Inflammatory bowel disease (20)
Inflation Reduction Act (5)
Influenza (17)
Intellectual property (17)
Interviews (322)
IPO (1080)
IRA (25)
Job creations (572)
Job search strategy (1109)
JPM (38)
Kidney cancer (2)
Labor market (55)
Layoffs (169)
Leadership (30)
Legal (1643)
Liver cancer (13)
Longevity (5)
Lung cancer (74)
Lymphoma (40)
Machine learning (16)
Management (42)
Manufacturing (157)
MASH (18)
Medical device (1289)
Medtech (1292)
Mergers & acquisitions (1901)
Metabolic disorders (308)
Multiple sclerosis (13)
NASH (4)
Neurodegenerative disease (60)
Neuropsychiatric disorders (22)
Neuroscience (443)
NextGen: Class of 2026 (1248)
Non-profit (948)
Now hiring (13)
Obesity (179)
Opinion (226)
Ovarian cancer (12)
Pain (34)
Pancreatic cancer (25)
Parkinson's disease (35)
Partnered (17)
Patents (50)
Patient recruitment (48)
Peanut (6)
People (5508)
Pharmaceutical (4)
Pharmacy benefit managers (10)
Phase I (2189)
Phase II (2851)
Phase III (2369)
Pipeline (549)
Policy (164)
Postmarket research (251)
Preclinical (843)
Press Release (8)
Prostate cancer (26)
Psychedelics (19)
Radiopharmaceuticals (27)
Rare diseases (204)
Real estate (801)
Recruiting (48)
Regulatory (2737)
Reports (8)
Research institute (530)
Resumes & cover letters (288)
Rett syndrome (5)
RNA editing (6)
RSV (13)
Schizophrenia (21)
Series A (43)
Series B (27)
Service/supplier (1)
Sickle cell disease (22)
Special edition (10)
Spinal muscular atrophy (19)
Sponsored (16)
Startups (546)
Stomach cancer (4)
Supply chain (21)
Tariffs (47)
The Weekly (33)
Vaccines (294)
Venture capital (44)
Weight loss (157)
Women's health (20)
Worklife (16)
Date
Today (1)
Last 7 days (61)
Last 30 days (243)
Last 365 days (3609)
2026 (248)
2025 (3701)
2024 (3720)
2023 (3862)
2022 (4866)
2021 (5707)
2020 (5675)
2019 (6141)
2018 (4815)
2017 (3585)
2016 (3793)
2015 (4185)
2014 (2789)
2013 (2154)
2012 (2397)
2011 (2456)
2010 (1672)
Location
Africa (324)
Alabama (7)
Alaska (1)
Arizona (14)
Arkansas (3)
Asia (3754)
Australia (892)
California (1219)
Canada (296)
China (106)
Colorado (44)
Connecticut (50)
Delaware (43)
Europe (9004)
Florida (136)
Georgia (18)
Idaho (5)
Illinois (83)
India (13)
Indiana (43)
Japan (37)
Kansas (22)
Kentucky (7)
Louisiana (6)
Maine (7)
Maryland (178)
Massachusetts (731)
Michigan (33)
Minnesota (39)
Mississippi (2)
Missouri (10)
Montana (5)
Nebraska (1)
Nevada (8)
New Hampshire (8)
New Jersey (254)
New Mexico (4)
New York (390)
North Carolina (102)
Northern California (513)
Ohio (33)
Oklahoma (4)
Oregon (5)
Pennsylvania (177)
Rhode Island (6)
South America (344)
South Carolina (10)
Southern California (480)
Tennessee (16)
Texas (175)
United States (3887)
Utah (35)
Virginia (27)
Washington D.C. (19)
Washington State (61)
West Virginia (2)
Wisconsin (18)
69,785 Results for "just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 8, 2026
·
5 min read
Press Releases
Evotec Closes Sale of Just - Evotec Biologics’ Toulouse Site to Sandoz
December 8, 2025
·
5 min read
Press Releases
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
January 28, 2026
·
4 min read
Editorial
Pazdur’s Sudden Exit Leaves Just Three Veterans in FDA’s Senior Ranks
Nearly 90% of senior leaders who were at the FDA a year ago are no longer with the agency, a
BioSpace
analysis shows. None remain from the Office of the Commissioner.
December 3, 2025
·
4 min read
·
Jef Akst
Press Releases
Glioblastomas Affect Much More Than Just the Brain
October 3, 2025
·
6 min read
Press Releases
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa
January 27, 2026
·
5 min read
Press Releases
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
January 29, 2026
·
8 min read
Press Releases
HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
October 15, 2025
·
4 min read
Press Releases
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
January 12, 2026
·
7 min read
Mergers & acquisitions
Just 9.5% of Life Sciences M&A Milestones Have Been Paid Since 2008
A new analysis from SRS Acquiom puts into perspective the headline values seen when a company announces a backloaded M&A deal. Biotechs have much on the line when they agree to deals with massive potential but little upfront.
October 1, 2025
·
2 min read
·
Annalee Armstrong
1 of 6,979
Next
